Home › Funds › Renaissance Technologies › ENVB
Renaissance Technologies position in ENVB
ENVERIC BIOSCIENCES INC · Health Care
Latest position (Q2 2026)32.06K sh
Reported value held$44.24K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 492.55K | $1.02M | New |
| Q4 2021 | 554.10K | $515.00K | Add |
| Q1 2022 | 1.99M | $657.00K | Add |
| Q2 2022 | 1.09M | $234.00K | Reduce |
| Q2 2023 | 17.17K | $58 | New |
| Q2 2025 | 37.01K | $44.78K | New |
| Q2 2025 | 37.01K | $44.78K | New |
| Q2 2026 | 32.06K | $44.24K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ENVB
- Citadel Advisors 13.96K sh · $19.27K · Q2 2026
- Geode Capital Management 11.79K sh · $16.27K · Q2 2026
- Morgan Stanley 10.73K sh · $14.81K · Q2 2026
- UBS Group AG 201 sh · $277 · Q2 2026
- BlackRock Inc 51 sh · $70 · Q2 2026
- Wells Fargo & Co 1 sh · $1 · Q2 2026